Abstract
Due to inherently greater risks of nonsterility, aseptic processes are considered inferior to terminal sterilization processes from a Sterility Assurance perspective. However, post aseptic fill sterilization and post aseptic lethal treatment processes can be performed as the terminal step of the manufacturing process to significantly reduce the risks of nonsterility for aseptic processes. Accordingly, incremental beneficial considerations could be achievable for these products and processes, including a reduction in environmental monitoring, a reduction in aseptic process simulation frequency, and/or a reduction or elimination of the finished product sterility test. Full compliance with current parametric release requirements would be a prerequisite to support the reduction or elimination of the finished product sterility test.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
